Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

GermanyBack to Germany

Clinical trials in Traunstein – page 2

21 clinical trials in Traunstein, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.

GermanyOur site in GermanyKlinischeStudien.de(opens in a new tab)
Traunstein at a glance
21
clinical trials
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

21 trials in Traunstein

Open in trial search

Efficacy of efgartigimod alfa as first‑line add‑on to IV methylprednisolone for moderate‑to‑severe attacks in patients with demyelinating diseases

Not yet recruiting
Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Efgartigimod Alfa
  • Sponsor:Medizinische Hochschule Hannover

Breast cancer+7

Not recruiting
Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:GBG Forschungs GmbH

Study on Reducing Side Effects in Advanced Hodgkin Lymphoma Using Brentuximab Vedotin and Drug Combination for Newly Diagnosed Patients

Not recruiting
Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Bleomycin Sulfate
  • Sponsor:University Of Cologne

Rectal cancer

Not recruiting
Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:Heidelberg University

Acute myeloid leukaemia

Not recruiting
Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Cytarabine
  • Sponsor:Universitaetsklinikum Ulm AöR

Colon cancer stage II+1

Not recruiting
Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:Technische Universitaet Dresden

Neoplasm malignant

Not recruiting
Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Atezolizumab
  • Sponsor:NSABP Foundation Inc.

Plasma cell myeloma

Not recruiting
Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Bortezomib
  • Sponsor:Universitaetsklinikum Schleswig-Holstein AöR

Mantle cell lymphoma stage II+2

Not recruiting
Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years
  • Substances:Ibrutinib
  • Sponsor:Klinikum Der Universitat Munchen AöR

Other cities in Germany

The busiest research cities in the country

All 515 cities in Germany

Clinical research in Traunstein

What the registry says about research in the country

01 Hematologic Oncology

Groundbreaking trials focusing on blood cancers and lymphomas, investigating innovative treatment combinations and targeted therapies.

  • Mantle Cell Lymphoma Studies
  • Acute Lymphoblastic Leukemia Research
  • Hodgkin Lymphoma Treatments

Novel therapeutic approaches combining targeted agents like ibrutinib with conventional chemotherapy protocols.

02 Solid Tumor Research

Comprehensive studies evaluating innovative treatments for various types of solid tumors, with particular focus on gastrointestinal and breast cancers.

  • Advanced Colon Cancer Therapies
  • Triple-Negative Breast Cancer Studies
  • Ovarian Cancer Treatments

Investigations into preoperative and adjuvant treatment strategies to improve patient outcomes.

03 Precision Medicine Initiatives

Advanced clinical trials implementing personalized treatment approaches based on specific genetic markers and patient characteristics.

  • Targeted Therapy Development
  • Biomarker-Driven Treatment
  • Immunotherapy Research

Focus on developing tailored therapeutic strategies for optimal treatment effectiveness.

Back to GermanyAll countries
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.